Alumis The Director, Medical Affairs at Alumis leads Medical content strategy, scientific readiness, and launch execution for envudeucitinib (ESK-001) in dermatology. This role ensures scientific accuracy and clinical relevance across Medical Review and supports internal and external scientific engagement.